UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
State Street SPDR S&P China ETF
GXC
$482M
| $5.73M | ﹤0.01% |
75,521
-5,104
| -6% | -$408K |
|
3677
Fortuna Silver Mines
FSM
$3.07B
| $5.72M | ﹤0.01% |
1,334,455
+729,816
| +121% | +$3.48M |
|
3678
Amphastar Pharmaceuticals
AMPH
$916M
| $5.71M | ﹤0.01% |
153,742
+52,710
| +52% | +$2.41M |
|
3679
Innodata
INOD
$2.04B
| $5.7M | ﹤0.01% |
144,331
+83,867
| +139% | +$2.64M |
|
|
FITB
3680
CALL
Fifth Third Bancorp
FITB
$51.8B
| $5.7M | ﹤0.01% |
134,800
+43,800
| +48% | +$1.97M |
|
|
STR
3681
DELISTED
Sitio Royalties
STR
| $5.7M | ﹤0.01% |
297,001
+124,144
| +72% | +$2.77M |
|
3682
CALL
Amcor
AMCR
$22.1B
| $5.69M | ﹤0.01% |
120,880
-43,980
| -27% | -$2.3M |
|
|
IGI
3683
Western Asset Investment Grade Defined Opportunity Trust
IGI
$94.9M
| $5.68M | ﹤0.01% |
348,540
-67,804
| -16% | -$1.14M |
|
3684
Braskem
BAK
$913M
| $5.68M | ﹤0.01% |
1,471,431
+1,471,430
| +147,143,000% | +$8.12M |
|
3685
CALL
Qiagen
QGEN
$8.72B
| $5.67M | ﹤0.01% |
+123,764
| New | +$5.54M |
|
3686
Humacyte
HUMA
$194M
| $5.66M | ﹤0.01% |
1,121,552
+937,539
| +509% | +$4.64M |
|
3687
iShares Morningstar Small-Cap Value ETF
ISCV
$706M
| $5.65M | ﹤0.01% |
89,124
+3,335
| +4% | +$217K |
|
3688
Aura Biosciences
AURA
$826M
| $5.65M | ﹤0.01% |
687,322
+665,336
| +3,026% | +$6.26M |
|
|
HAPN
3689
Happen Inc
HAPN
$2.24B
| $5.64M | ﹤0.01% |
348,629
+281,470
| +419% | +$4.15M |
|
3690
Emergent Biosolutions
EBS
$248M
| $5.64M | ﹤0.01% |
590,221
+321,783
| +120% | +$2.95M |
|
3691
Nuveen ESG Emerging Markets Equity ETF
NUEM
$384M
| $5.64M | ﹤0.01% |
194,324
-5,216
| -3% | -$159K |
|
3692
OraSure Technologies
OSUR
$279M
| $5.64M | ﹤0.01% |
1,561,018
+1,529,001
| +4,776% | +$6.09M |
|
3693
CALL
SkinHealth Systems
SKIN
$85.7M
| $5.63M | ﹤0.01% |
3,542,164
| – | – |
|
3694
Northwest Bancshares
NWBI
$2.28B
| $5.63M | ﹤0.01% |
426,958
+201,010
| +89% | +$2.79M |
|
|
CYBR
3695
CALL
DELISTED
CyberArk
CYBR
| $5.63M | ﹤0.01% |
+16,900
| New | +$5.14M |
|
3696
iShares Core MSCI Pacific ETF
IPAC
$2.77B
| $5.62M | ﹤0.01% |
91,995
+8,885
| +11% | +$565K |
|
|
ARTY
3697
iShares Future AI & Tech ETF
ARTY
$3.81B
| $5.62M | ﹤0.01% |
151,525
-8,070
| -5% | -$293K |
|
3698
iShares MSCI Poland ETF
EPOL
$756M
| $5.62M | ﹤0.01% |
269,102
-91,720
| -25% | -$2.06M |
|
3699
National Bank Holdings
NBHC
$1.9B
| $5.62M | ﹤0.01% |
130,415
+96,144
| +281% | +$4.35M |
|
3700
Davis Select Worldwide ETF
DWLD
$613M
| $5.61M | ﹤0.01% |
154,615
+8,457
| +6% | +$323K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.